Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:ATNX

Athenex (ATNX) Stock Price, News & Analysis

Athenex logo

About Athenex Stock (NASDAQ:ATNX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.20
$1.52
52-Week Range
N/A
Volume
1.88 million shs
Average Volume
194,316 shs
Market Capitalization
$1.76 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ATNX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Athenex and its competitors with MarketBeat's FREE daily newsletter.

ATNX Stock News Headlines

The #1 AI Energy Stock
Nearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being built now will dwarf everything that came before them. Thanks to AI's ravenous hunger for power … They are beginning to morph into sprawling behemoths.
Athenex (NASDAQ: ATNX)
See More Headlines

ATNX Stock Analysis - Frequently Asked Questions

Athenex, Inc. (NASDAQ:ATNX) announced its earnings results on Thursday, November, 4th. The company reported ($0.33) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.41) by $0.08. The firm had revenue of $32.30 million for the quarter, compared to analyst estimates of $19.40 million. Athenex had a negative net margin of 86.31% and a negative trailing twelve-month return on equity of 727.79%.

Athenex (ATNX) raised $72 million in an initial public offering (IPO) on Wednesday, June 14th 2017. The company issued 6,000,000 shares at a price of $11.00-$13.00 per share. Credit Suisse, Deutsche, Bank Securities and J.P. Morgan served as the underwriters for the IPO and ICBC International was co-manager.

Based on aggregate information from My MarketBeat watchlists, some other companies that Athenex investors own include TherapeuticsMD (TXMD), Meta Platforms (META), Sorrento Therapeutics (SRNE), NIO (NIO), NVIDIA (NVDA), Tesla (TSLA) and Ford Motor (F).

Company Calendar

Last Earnings
11/04/2021
Today
7/01/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:ATNX
Fax
N/A
Employees
652
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$103.43 million
Pretax Margin
-95.92%

Debt

Sales & Book Value

Annual Sales
$102.82 million
Price / Cash Flow
N/A
Book Value
($3.07) per share
Price / Book
N/A

Miscellaneous

Free Float
7,866,000
Market Cap
$1.76 million
Optionable
Optionable
Beta
1.36

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:ATNX) was last updated on 7/1/2025 by MarketBeat.com Staff
From Our Partners